Usinganautomated immunoprecipftin method, we assayed human sera for 10 proteins: haptoglobin, orosomucoid, transferr in, a1-antltrypsin, a2-macroglobulin, lgG, IgA, 1gM, complement C3, and complement C4. Blood from 14 healthy subjects (25-40 y) was sampled on six separate days. From each venipuncttre serum was divkied into foti' aliquots; two were assayedon the day of venipuncttre and two were frozen and kept until the end of the study, when all of the frozen samples were analyzed in one batch. With this experimental design, batch-to-batch analytical variation could be estimated, and we avoided confounding it with the biological variation. Data analysis was based on the analysis of variance technique. The average physiological intra-individual coefficient of variation ranged from 2.5% for transferrin to 11.1 % for orosomucoid. The interindividual variation ranged from 9.5% for transferrin to 70.5% for haptoglobin and the ratio between intra-individual variation and interindividual variation ranged from 0.06 for 1gMto 0.26 for orosomucoid and transferrin.
Previously we have examined the biological components of variation for some analytes in sera of healthy subjects (1) . In general, we found a relatively large value for the ratio of the variation occurring within a subject to the variation in mean values among subjects. When the ratio (intra-subject variation/inter-subject variation) is small, the use of the conventional reference limits based on single sample values from a group of healthy subjects may be essentially misleading for the purpose of monitoring the results for a particular subject. Therefore data should be accumulated to estimate the inter-subject variation of mean values and the intra-subject variations (2).
Methods and Materials
Subjects: Fourteen healthy volunteers, 25-40 years of age, were used in this study; all were graduate students or employees of the routine chemistry laboratory at the North Carolina Memorial Hospital. Subjects 1-8 were men, subjects 9-14 women. None of the women was taking oral contraceptives.
The start of the last menstrual periods for the women was as follows: subject 9: July 19; subject 10: Nov. 24; subject 11: Nov. 30; subject 12: Dec. 1; subject 13: Nov. 4; and subject 14: Nov. 22, 1975. All subjects were within 15% of their idealized weight.
Specimen collection. On six days (December 2, 3, 4, 8, 9, and 11, 1975) each of the subjects came to work without having breakfasted and then sat for at least 15 mm before an experienced phiebotomist applied a tourniquet and filled a glass tube with about 15 ml of whole blood. All venipunctures were done between 0800 and 0830 h.
Processing of specimens:
The whole blood was allowed to clot at room temperature and then centrifuged. The serum was decanted and then separated into four equivalent aliquots, two of which (per venipuncture) were assayed the same day of venipuncture and two frozen. Thus from each day's venipunctures we obtained 56 serum aliquots (four per venipuncture X 14 subjects); of these, 28 aliquots (two per venipuncture X 14) were assayed on the same day. Before assay they were given identification numbers and their order was randomized. The remaining 28 specimens were frozen at -20 #{176}C. At the conclusion of the study we had 168 frozen specimens (28 X 6). Two days after the date of the last venipuncture session the order of these 168 specimen was randomized and they were all assayed in one batch. ment. All antisera were obtained commercially (Technicon Corp., Tarrytown, N.Y. 10591 and Atlantic Antibodies, Westbrook, Me. 04092), and were diluted with a saline polyethylene glycol solution (9 g NaCl/liter; "PEG 6000," mol wt 6000-7500, 40 g/liter) before use. All samples were diluted 100-fold with an automatic pipette (Model 25000; MicroMedic Systems, Inc., Philadelphia, Pa. 19104) before being aspirated into the continuous-flow manifold. Determinations were then done at 100 samples per hour on the automated threechannel system. We accepted the labeled values established by the manufacturer for the concentration of the calibration materials. None of the specimens was grossly hemolyzed.
In addition, each serum specimen was assayed for alkaline phosphatase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase, and creatine kinase activities, and for cholesterol, triglycerides, thyroxine, and cortisol. The serum specimens for subjects 1, 2, 3, 4, 7, and 8 were also assayed for y-glutamyl transpeptidase.
For the determinations of the enzyme activity, the 12 specimens from each subject (six days X two duplicates) were dispensed into 12 places of the transfer disc of a Rotochem centrifugal analyzer (American Instrument Co., Silver Spring, Md. 20910) along with control sera. All activities were measured at 30 #{176}C. Alkaline phosphatase activity was measured by using 15 mmol/liter p-nitrophenylphosphate as substrate in 2-amino-2-methyl-1-propanol buffer, pH 10.2; creatine kinase activity was measured with a "Statzyme CPK" kit from Worthington Biochemical Corp. (CPK:7251). The activities of the four other enzymes were measured with kits from Boehringer Mannheim Corp. Cholesterol was assayed by using a single-vial reagent (Beckman Microbics, Carlsbad, Calif. 92008) that contains cholesterol esterase, cholesterol oxidase, and the peroxidase/phenol/4-aminontipyrine system. Triglycerides were determined with the two-vial "Super Stat-Pack" (Calbiochem, San Diego, Calif. 92112) and by using the centrifugal analyzer. Thyroxine was measured with the "Gammacoat Radioimmunoassay Kit" (Clinical Assays, Cambridge, Mass. 02142). Cortisol was assayed with the "Gammacoat 125J Cortisol Radioirnmunoassay Kit" (Clinical Assays).
Statistical methods: The first data set (data set I) to be analyzed comprised the results of the assays performed on each of the six experimental days (14 subjects X six days )< two duplicates, or 168 sets of 10 protein values). For each of the 10 proteins these data were analyzed according to a two-way ANOVA model with the factors being "subject"
and "day." The analytical components of the variation were estimated from the error term (within-batch variation) and the main day effect (batch-to-batch variation). The latter term reflects the variation of the six daily grand means. The biological components of variation were derived from the main subject effect (interindividual variation of mean levels) and the subject-day interaction term (average intra-individual variation) (1) . The subjectday interaction term was used to test for both the main subject and main day effects. The data set containing the results on the frozen sera (data set II) was also analyzed according to a two-way ANOVA in the same way as described above. Both analytical and biological components of variation are presented in terms of coefficients of variation. Table 1 presents the mean values as well as the within-batch and batch-to-batch variation as computed from data set I. The batch-to-batch analytical variation (estimated by the main day effect of the two-way ANOVA) was statistically significant for all the proteins (P <0.01) except haptoglobin and complement C4 (P > 0.05). By contrast, when we did the same analysis of the results obtained from the frozen sera, a statistically significant analytical batch-to-batch variation could only be demonstrated for one of the proteins (complement C4), and only at the 5% level of significance.
Results

Analytical components of variation:
Biological components of variation: Figures 1,2 , and 3 present the ranges of values for each of the subjects for IgA, haptoglobin, and complement C4 over the study period. The substantial differences among the means of each of the subjects can be appreciated for these proteins. In the cases of haptoglobin, orosomucoid, 1gM, and IgA, the interindividual variation of mean values exceeds 40% (Table 2) . Figure 4 illustrates, for nine of the subjects, the relatively small intra-individual variation of concentration values of 1gM as compared to the much greater interindividual variation.
The interindividual variations and the average intra-individual variations (as determined from the two-way ANOVA of data set I) for each of the 10 serum proteins are presented in Table 2 . For comparison, we also present corresponding results for six enzymes, two lipids, and two hormones-all assayed on the same serum specimens we used for this study. In all cases (10 proteins, six enzymes, two lipids, and two hormones), The ratio values (intra-subject variation/inter-subject variation) comparing the mean intra-individual CV to the interindividual CV are also presented in Table 2 . In no case is the ratio value above 0.26 for any of the serum proteins. This is contrasted to the situation for four of the enzyme activities, and for triglycerides and cortisol, where the ratios are all above 0.35.
Discussion
Our main purpose here was to estimate the intraindividual and interindividual biological variations of specific proteins in healthy subjects. To do this it was necessary to design the experiments so that biological and analytical components of the total variation could be separately computed. We determined the withinbatch analytical variation on the basis of the variation of the results for the duplicate samples, a term that in- cludes both instrumental error and part of the preinstrumental variation. The pre-instrumental sources of variations in this instance include the separation of the specimens into aliquots, processing and transporting of the sera, and the effects of a variable "waiting time" before analysis. We randomized all the duplicate samples in order not to confound variation from any drift in the instrument and any possible sample carryover with the biological sources of variation.
The batch-to-batch analytical variation as determined on the basis of the variance of the six daily grand means theoretically would include any seasonal factor affecting the group as a whole, a possibility that seems very unlikely, especially during a 10-day period. Furthermore, using the data set based on the results of the frozen sera, we found a significant (P < .05) main day effect for only one of the 10 proteins, which would be expected by chance alone.
Harris has explored the theoretical aspects of the relationship of the mean intra-individual variation to the interindividual variation. He pointed out that if the average ratio value (intra-subject variation/intersub ject variation) is small and if one assumes gaussian distributions, the conventional normal range would include a larger than expected proportion of an individual's distribution of results (2). The ratios between intra-subject and inter-subject variation were very low for all the proteins that we examined: all 10 ratio values were less than 0.3 (excluding analytical variation). Thus, for the specific proteins, we believe that using a person's baseline values (while he is in good health) is preferable to using the much broader group reference interval. This same argument could be used for activity values of alkaline phosphatase and y-glutamyltransferase (EC 2.3.2.2) where the ratio values were very small. Certainly from a preventive medicine perspective or when following the course of a patient for recurrence of a disease, where we are interested in noting incipient changes before clinical manifestations become obvious, the individual's personal reference intervals for concentrations of serum proteins should be evaluated prospectively for later use as an indication of change in his status.
